Transgenic perspectives in xenotransplantation, 2001

Xenotransplantation

Volumn 9, Issue 5, 2002, Pages 305-308

  Nottle, Mark B ^a   D'Apice, Anthony J F ^b   Cowan, Peter J ^b   Boquest, Andrew C ^a   Harrison, Sharon J ^a   Grupen, Christopher G ^a  

^a BresaGen Limited   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GENE TARGETING; INFECTION RISK; KNOCKOUT GENE; NONHUMAN; NOTE; PRIORITY JOURNAL; TRANSGENE; XENOTRANSPLANTATION;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; GENE TARGETING; GENOME; GRAFT REJECTION; HUMANS; PRIMATES; SWINE; TRANSGENES; TRANSPLANTATION, HETEROLOGOUS;

EID: 0036766246     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3089.2002.t01-1-02036.x     Document Type: Note

References (32)

1. d'APICE AJF, NOTTLE MB, COWAN PJ. Genetic modification for xenotransplantation: transgenics and clones. Transplant Proc 2001; 33: 3053.
2. NOTTLE MB, HASKARD KA, VERMA PJ et al. Effect of DNA concentration on transgenesis rates in mice and pigs. Transgenic Res 2001; 10: 523.
3. WALL RJ. Pronuclear microinjection. Cloning Stem Cells. 2001; 3: 209.
4. COWAN PJ, AMINIAN A, BARLOW H et al. Renal xenografts from triple transgenic pigs are not hyperacutely rejected but cause coagulopathy in non-immunosupressed baboons. Transplantation 2000; 69: 2504.
5. ADAMS DH, KADNER A, CHEN RH, FARIVAR RS. Human membrane cofactor protein (MCP, CD 46) protects transgenic pig hearts from hyperacute rejection in primates. Xenotransplantation 2001; 8: 36.
6. BENNET W, BJORKLAND A, SUNDBERG N et al. Expression of complement regulatory proteins on islets of Langerhans: a comparison between human islets and islets isolated from normal and hDAF transgenic pigs. Transplantation 2001; 72: 312.
7. BUHLER L, YAMADA K, KITAMURA H et al. Pig kidney transplantation in baboons: anti-Gal (alpha)1-3Gal IgM alone is associated with acute humoral xenograft rejection and disseminated intravascular coagulation. Transplantation 2001; 72: 1743.
8. CARRINGTON CA, DOS SANTOS CRUZ G. Effect of cell surface concentration of human DAF on transgenic pig aortic endothelial cells on the degree of protection afforded against human complement deposition. Xenotransplantation 2001; 8: 100.
9. CHEN RH, ADAMS DH. Transgenic porcine valves show no signs of delayed cardiac xenograft rejection. Aim Thorac Surg 2001; 71: S389.
10. DIAMOND LE, QUINN CM, MARTIN MJ et al. A human CD46 transgenic pig model system for the study of discordant xenotransplantation. Transplantation 2001; 71: 132.
11. HUANG J, GOU D, ZHEN C et al. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP. FEMS Immunol Med Microbiol 2001; 31: 203.
12. MIYAGAWA S, MURAKAMI H, TAKAHAGI Y et al. Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig. J Biol Chem 2001; 276: 39310.
13. NIEMANN H, VERHOEYEN E, WONIGEIT K et al. Cytomegalovirus early promoter induced expression of hCD59 in porcine organs provides protection against hyperacute rejection. Transplantation 2001; 72: 1898.
14. PRZEMECK M, VANGEROW B, LOSS M et al. Hemodynamic consequences of porcine kidney xenograft reperfusion in cynomolgus monkeys. Transplantation 2001; 71: 1512.
15. SANTERRE D, CHEN RH, KADNER A et al. Anaesthetic management of baboons undergoing heterotopic porcine cardiac xenotransplantation. Vet Res Commun 2001; 25: 251.
16. SOIN B, SMITH KG, ZAIDI A et al. Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int 2001; 60: 1592.
17. LANGFORD GA, GALBRAITH D, WHITTAM AJ et al. In vivo analysis of porcine endogenous retrovirus expression in transgenic pigs. Transplantation 2001; 72: 1996.
18. SWITZER WM, MICHLER RE, SHANMUGAM V et al. Lack of cross-species transmission of porcine endogenous retrovirus infection to nonhuman primate recipients of porcine cells, tissues, or organs. Transplantation 2001; 71: 959.
19. SPECKE V, TACKE SJ, BOLLER K, SCHWENDEMANN J, DENNER J. Porcine endogenous retroviruses: in vitro host range and attempts to establish small animal models. J Gen Virol 2001; 82: 837.
20. TACKE SJ, BODUSCH K, BERG A, DENNER J. Sensitive and specific immunological detection methods for porcine endogenous retroviruses applicable to experimental and clinical xenotransplantation. Xenotransplantation 2001; 8: 125.
21. NOTTLE MB, NAGASHIMA H, VERMA PJ et al. Developments in transgenic techniques in pigs. J Reprod Fertil Dev 1997; 52: 237.
22. WILMUT I, SCHNIEKE AE, MCWHIR J, KIND AJ, CAMPBELL KHS. Viable offspring derived from fetal and adult mammalian cells. Nature 1997; 385: 810.
23. POLEJAEVA IA, CHEN SH, VAUGHT TD et al. Cloned pigs produced by nuclear transfer from adult somatic cells. Nature 2000; 407: 505.
24. BETTHAUSER J, FORSBERG E, AUGENSTEIN M et al. Production of cloned pigs from in vitro systems. Nat Biotechnol 2000; 18: 1055.
25. ONISHI A, IWAMOTO M, AKITA T et al. Pig cloning by microinjection of fetal fibroblast nuclei. Science 2000; 289: 1188.
26. DAI Y, VAUGHT TD, BOONE J et al. Targeted disruption of the α1,3-galctosyltransferase gene in cloned pigs. Nat Biotechnol 2002; 20: 251.
27. LAI KL, KOLBER-SIMONDS D, PARK KW et al. Production of α1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002; 295: 1089.
28. CAMPBELL KHS, ALBERIO R, LEE JH, RITCHIE WA. Nuclear transfer in practice. Cloning Stem Cells 2001; 3: 201.
29. DENNING C, DICKINSON P, BURL S et al. Gene targeting in primary fetal fibroblasts from sheep and pig. Cloning Stem Cells 2001; 3: 221.
30. SAUER B. Inducible gene targeting in mice using the Cre/lox system. Methods 1998; 4: 381.
31. KITAMOTO T, NAKAMURA K, NAKAO K et al. Humanized prion protein knock-in by Cre-Induced site-spccific recombination in the mouse. Biochem Biophys Res Comms 1996; 222: 742.
32. SIEGEL RW, JAIN R, BRADBURY A. Using an in vivo phagemid system to identify non-compatible loxP sequences. Federation Eur Biochem Soc Lett 2001; 505: 467.